Previous studies have demonstrated that these Ptpn11 gain-of-function (GOF) mutations are sufficient to drive the development of JMML-like myeloproliferative disorder (MPD) and malignant acute leukemias in mice [23], [26], [27], [28], [29]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.